Skip to main content

Understanding the Artificial Pancreas in 3 simple points


                                 This image is a diagram showing each part that makes up an artificial pancreas.  It has items numbered one through four.  Item one is the continuous glucose monitor.  Item two is the computer-controlled algorithm.  Item three is the insulin pump.  Item four is the patient effect.
                                   Source - https://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/HomeHealthandConsumer/ConsumerProducts/ArtificialPancreas/ucm259548.htm

What is the Artificial Pancreas?

One of the most exciting breakthroughs our times, the Artificial Pancreas is a device that will automate the checking of blood glucose level and the dispensing(or withholding) of insulin (according to the glucose level in the blood).

The system is made up of a sensor that measures blood glucose under the skin; an insulin pump; an infusion patch that delivers insulin from the pump via a catheter inserted into the skin and a computer chip that uses data to optimize insulin delivery by the minute.

(More info - http://www.diabetesincontrol.com/fda-approves-first-artificial-pancreas/)


The technology

This technology will give a huge relief to diabetes sufferers, especially those suffering from Type 1 Diabetes. No more pricking yourself for blood sugar measurement six time a day and no more making the lengthy calculation of the amount of insulin to be taken based on what you eat.

The Artificial Pancreas will do all of this for you while you go about your day.

How will it function?

The Artificial Pancreas will be first available as an external device to be worn around your waist, It will measure the glucose levels and directly administer the insulin into the patients blood stream.

The FDA in USA has already given approval for it and the device is expected to hit the market soon.

Comments

Popular posts from this blog

Pancreatic Rest - The cure to Diabetes type 2

Shocked? Well apparently the cure to Diabetes Mellitus or Type 2 Diabetes has been in front of our eyes all along. Type 2 diabetes, is a condition where the body fails to regulate the sugar levels in the blood causes too much or too little insulin to be produced by the pancreas. It usually turns into a life long disease requiring diet control and insulin therapy. According to new research, conducted at McMaster university in Canada, there may be hope for type 2 suffers through an intensive program that involves closely monitoring of diet+exercises+insulin+oral medicines. It basically involves giving rest to your pancreas after which your pancreases returns to normal (according to 40% of the results of study) and you are cured of diabetes or your diabetes is reversed, atleast temporarily. Here are some of the numbers as shared by McMaster University Research Program: 41% of the participants saw their diabetes reverse in just four months after the intensive program. The trial...

Why the new Mental Health bill is being hailed by everyone in India right now

Mental health in India has always been greatly stigmatized. We are extremely judgmental of people who say they are depressed and approach a psychiatrist for the same. We talk behind their back and generally brand them as 'mental case'. It wasn't until recently Deepika Padukone followed by a number of other celebs disclosed being depressed and having various mental ailments that to some level it seems that we have reached a stage where we can atleast have a conversation about it.  Recently the mental health care bill of 2013 was passed, that updated a lot of definitions of what constitutes mental health. It has been hailed by the general public as a step in the right direction. Here are some of the salient features of the bill that have really been appreciated by everyone.    1. First and most importantly, the mental health bill decriminalizes suicide. Viewed as a revolutionary move, the bill acknowledges the various mental factors contributing to a person...

NPPA India slashes Cancer drugs price

Nation Pharmaceutical Pricing Authority (NPPA) has been on a roll - first reducing the cost of life saving drugs and then reducing the cost of stents in India. Championing the cause of affordable medicine further, NPAA has further reduced the cost life saving cancer drugs, some by as much as 85%. The drugs include Iressa of AstraZeneca Pharma India, whose price has been bought down from Rs 29,259 to Rs 3,977, a reduction of 86 per cent and Dr Reddy's laboratories' Grafeel - the price of which has been slashed by 41 per cent, it said.  The reduction is in the price range of 86 per cent to 13 per cent, NPPA said. The other pharma players the prices of whose cancer medicines have been reduced are  Natco Pharma  and Emcure pharmaceuticals among others, it added. In the diabetes segment also, there has been reduction in prices of the drugs, the regulator said. Source (Times of India)